CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

Greater Nashua Mental Health

Greater Nashua Mental Health believes in empowering people to lead full and satisfying lives through effective treatment and support.

Unetixs Vascular

InforMed Direct

InforMed Direct is a Haddam, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EMSAR

You can depend on us. Our mission is to provide quality equipment services and repairs to our valued customers across the U.S. and Canada.

Cognosci

Cognosci is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.